David Starr has extensive management and leadership experience in life sciences and consumer products spanning all facets of operations and company stages – from company formation through explosive growth. His experience includes product definition, market research and analysis, distribution planning, sales management, product and technical support, manufacturing planning, financial operations, HR, engineering management, intellectual property and patent strategy, quality and regulatory management, fund raising, business development, clinical study design, medical education, healthcare economics and reimbursement.

Mr. Starr has spent the past 25 years in the medical device sector with an eye towards developing affordable, and easy to use medical technology that address today’s critical needs and what it takes to achieve commercial success. He is adept at working with clinicians in a variety of specialties to focus efforts on what is clinical actionable, “doable” from an engineering perspective and address large markets with clear unmet needs. These clinical areas include, emergency medicine, trauma, cardiology, radiology, anesthesiology, nursing, primary care, and first responders. Mr. Starr has raised over $50 million of investor money from angels, corporations, and venture capital firms including several overseas VC’s.

Most recently, as CEO of Sonivate Medical, Inc., he led the restart and turnaround of an innovative point-of-service ultrasound technology, shedding more than $1 million in debt and raising nearly $7 million, including $5 million in non-dilutive funding from the US Department of Defense. Mr. Starr focused the engineering efforts, restructured operations, and led marketing and business development. Sonivate won several awards including best of show at two major trade conferences and won two prestigious angel investor conferences.

Mr. Starr co-founded Inovise Medical, Inc., developer of the Atlas patient monitor, which was ultimately funded and distributed by Welch-Allyn as the first low cost patient monitor for outpatient surgery environments. He worked closely with the engineering team and clinicians to invent the company’s proprietary cardiac diagnostic technology, design clinical studies, and author publications. As Chief Operating Officer and VP Marketing, Mr. Starr was directly involved in raising over $50 million together with the company CEO.

At HP Medical Mr. Starr developed the defibrillator strategy that led to tremendous growth in use of this technology beyond hospital settings. He was also part of the original HP DeskJet printer introduction team that presided over rapid growth from $200 million in revenue to more than $3 billion in five years.

Mr. Starr started his career in the venture capital business as an associate at Shaw Venture Partners directly out of business school. This experience led him to gain valuable operating experience and what it takes to create and grow a business.

His degrees include a BA, cum laude, from Pomona College and an MBA from the University of Chicago.